论文部分内容阅读
目的探究病毒性腹泻患儿通过喜炎平配合双歧杆菌与利巴韦林治疗后取得的临床成效。方法选取我院收治的病毒性腹泻患儿80例,且均在2014年1月至2016年6月入院,依随机分组标准分为观察组(40人)和对照组(40人)。对照组患儿治疗方法为利巴韦林治疗,观察组为喜炎平配合双歧杆菌与利巴韦林联合治疗。从临床治疗有效率方面入手,针对相关内容进行分析。结果对照组治疗总有效率(75%)比观察组(95%)低(P<0.05)。结论病毒性腹泻患儿通过喜炎平配合双歧杆菌与利巴韦林治疗后,使治疗效果明显增高,存在一定推广价值。
Objective To investigate the clinical efficacy of Xiyanping combined with Bifidobacterium and ribavirin in children with viral diarrhea. Methods Eighty children with viral diarrhea admitted to our hospital were enrolled and were admitted to our hospital from January 2014 to June 2016. The patients were randomly divided into observation group (40 persons) and control group (40 persons). Control group treatment of children with ribavirin treatment, observation group Xiyan Ping with bifidobacterium and ribavirin combination therapy. Starting from the clinical treatment efficiency, analysis of the relevant content. Results The total effective rate (75%) in the control group was lower than that in the observation group (95%) (P <0.05). Conclusion Children with viral diarrhea through Xiyanping with bifidobacteria and ribavirin treatment, the treatment effect was significantly increased, there is a certain promotional value.